Year: 2025

Reference is made to the stock exchange announcement made by Havila Kystruten AS on 7 November 2025 regarding the resolution by an extraordinary general meeting in the Company to conduct a reverse share split in the ratio of 50:1, to conduct a share capital increase to increase the number of shares in the Company to a number divisible by 50, and to change the ISIN of the Company’s shares. Reference is also made to the announcement regarding key information related to the reverse share split and change of ISIN. The share capital increase and the reverse share split has today been registered with the Norwegian Register of Business Enterprises: Share capital (new): NOK 855,985,700.00 Total number of shares (new): 17,119,714.00 Nominal value per share: NOK 50.00 Contacts: Chief Executive Officer: Bent Martini, +47 905 99 650 Chief Financial...

Quadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business connections, announced today that it has once again been recognized among the Top 3 French software publishers in the “Horizontal Solutions” category, according to the 15th edition of the EY and Numeum ranking. The company also secured the 17th position overall in the Top 250, reaffirming the strength of its growth and the consistent execution of its Elevate to 2030 strategic plan, which is centered on customer-driven innovation and long-term value creation. The EY and Numeum Top 250 report provides an annual overview of the French software industry’s performance and key trends. In 2024, despite a cautious economic climate, the sector demonstrated resilience with a growth rate of 7.4%, reaching €23.1 billion in revenue. Within this...

VILVI Group, which consists of Vilkyškių pieninė AB, Modest AB, Kelmės pieninė AB, Kelmės pienas UAB, Pieno logistika AB and Baltic Dairy Board SIA, consolidated sales for October 2025 amounted EUR 25.99 million – 10.1% increase comparing to October 2024. The consolidated sales of the Group for period January – October 2025 amounted to EUR 241.81 million – 18.0% increase comparing to the same period last year. Vilija Milaseviciute          Economics and finance director Phone: +370 441 55 102 Email: vilija.milaseviciute@vilvi.eu

Nokia CorporationStock Exchange Release10 November 2025 at 09:45 EET Nokia appoints Kristen Pressner as Chief People Officer and member of the Group Leadership Team Espoo, Finland – Nokia today announced the appointment of Kristen Pressner as Chief People Officer and member of the Group Leadership Team, effective 1 May 2026. Pressner has over 30 years of international experience in HR, talent management, and organizational transformation. She joins Nokia from Roche Holding Group, where she most recently served as Global Head of People & Culture for Roche Diagnostics. Across her tenure at Roche Holding, she played a key role in strengthening leadership, evolving the company’s operating model, and shaping a culture that enables innovation and drives business impact. Earlier in her career at Texas Instruments, she held various HR leadership...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange announcement by Hofseth Biocare ASA (“HBC” or the “Company”) on 27 October 2025 regarding completion of a private placement (the “Private Placement”) of new shares in the Company, and to the stock exchange announcement on 7 November 2025 regarding the terms and conditions for a subsequent offering of up to 16,666,666 new Ordinary Shares in the Company (the “Offer Shares”), each at the same subscription price per Offer Share as the subscription...

Caledonia Delivers Strong Q3 2025 Revenue Amid Growth Plans ST HELIER, Jersey, Nov. 10, 2025 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (“Caledonia” or “the Company”, and, together with its subsidiaries, “the Group”) NYSE AMERICAN, AIM, VFEX: CMCL. Consolidated statements of profit or loss and other comprehensive income, consolidated statements of financial position and consolidated statements of cash flows are included in the appendices at the end of this announcement. SUMMARYIn September the Company announced a Blanket Mine (“Blanket”) employee fatality following an accident related to secondary blasting. A comprehensive review of safety procedures and training is underway. Gold production of 19,106 ounces (“oz”), and gold sales of 20,355 oz from Blanket, with 2,861 oz of gold bullion on hand at the quarter-end, which...

Press release  Trifork Labs company Arkyn announces €4m financing to accelerate growth and expand product suite Copenhagen, 10 November 2025 – Arkyn, the leading digital platform for service and asset maintenance operations on top of SAP, today announces a EUR 4 million financing co-led by Compounding Capital and Trifork Labs. The Danish enterprise software company, headquartered in Copenhagen, brings real-time ERP data into the day-to-day maintenance life cycle, asset utilization, and performance measurements to support informed decisions that optimize maintenance strategies, improve asset performance, and increase reliability in the field and at the plant. All through a highly modern, user-friendly frontline worker app suite that is fully integrated into SAP in real-time from planning to execution and reporting. The financing will fuel...

Preclinical studies demonstrated significant efficacy on systemic inflammation and organ function in ACLF disease models Safety data from Phase 1 on healthy volunteers and initial efficacy signals from ex-vivo functional assays expected by year-end 2025Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), November 10, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today presents promising new preclinical data in ACLF at The Liver Meeting® 2025 with nitazoxanide (NTZ). GENFIT is advancing NTZ through a novel formulation, investigational drug G1090N, which serves as the cornerstone of our ACLF pipeline and reflects our commitment to addressing critical unmet needs in liver disease. G1090N...

Sampo plc, stock exchange release, 10 November 2025 at 8:30 am EET Sampo plc’s share buybacks 7 November 2025 On 7 November 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  7,674 9.81 AQEU    110,130 9.81 CEUX  26,983 9.80 TQEX  101,772 9.81 XHELTOTAL 246,559 9.81  * rounded to two decimals                      On 5 November 2025, Sampo announced a share buyback programme of up to a maximum of EUR 150 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 6 November...

EVerZom’s investigational drug candidate EViv, developed to treat ACLF, using its proprietary exosome platform, represents a novel approach to regenerative therapies Pending successful in vivo proof-of-concept results, GENFIT has an exclusive option to take a license to drive EViv into clinical development Under this research collaboration, EVerZom will contribute exosome expertise with associated bioproduction platform, while GENFIT will spearhead preclinical evaluation of EVivLille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), November 10, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announces a research collaboration with EVerZom to expand its Acute-On-Chronic Lier Failure...